Insider Transactions Screener

Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.

Ticker Insider Transaction Type Ownership Type Shares Traded Value / Price Filing Date
ONB
Andrew E Goebel

Director
BUY
Other acquisition or disposition
Indirect 5 Added 0.83%
$84 $16.72 p/Share
Dec 15
2020
ONB
Daniel S Hermann

Director
BUY
Other acquisition or disposition
Direct 196 Added 0.82%
$3,277 $16.72 p/Share
Dec 15
2020
ONB
Rebecca S Skillman

Director
BUY
Other acquisition or disposition
Direct 189 Added 0.82%
$3,160 $16.72 p/Share
Dec 15
2020
ONB
Derrick J Stewart

Director
BUY
Other acquisition or disposition
Direct 57 Added 0.82%
$953 $16.72 p/Share
Dec 15
2020
ONB
Kendra L Vanzo

CHIEF ADMINISTRATIVE OFFICER
BUY
Other acquisition or disposition
Direct 6 Added 0.83%
$100 $16.72 p/Share
Dec 15
2020
ONB
Linda Elaine White

Director
BUY
Other acquisition or disposition
Direct 52 Added 0.82%
$869 $16.72 p/Share
Dec 15
2020
ABT
Funck, Jr. Robert E.

EXECUTIVE VICE PRESIDENT
BUY
Bona fide gift
Indirect 20,000 Added 50.0%
-
Dec 15
2020
ABT
Funck, Jr. Robert E.

EXECUTIVE VICE PRESIDENT
SELL
Bona fide gift
Direct 20,000 Reduced 10.98%
-
Dec 15
2020
ABT
Michael J Pederson

SENIOR VICE PRESIDENT
SELL
Bona fide gift
Direct 6,000 Reduced 8.4%
-
Dec 15
2020
BUDZ
Nicole M Breen

Secretary/Treasurer
SELL
Open market or private sale
Indirect 7,000 Reduced 0.03%
$1,750 $0.25 p/Share
Dec 15
2020
NWPP
Harold L Keene

Director
BUY
Open market or private purchase
Indirect 13 Added 0.0%
$25 $1.95 p/Share
Dec 15
2020
CMPI
Arthur M Krieg

Chief Scientific Officer
BUY
Open market or private purchase
Direct 42 Added 0.01%
$609 $14.49 p/Share
Dec 15
2020
CLGX
W Steve Albrecht

Director
BUY
Grant, award, or other acquisition
Direct 4 Added 0.39%
-
Dec 15
2020
CLGX
Douglas C Curling

Director
BUY
Grant, award, or other acquisition
Direct 17 Added 0.04%
-
Dec 15
2020
CLGX
John C Dorman

Director
BUY
Grant, award, or other acquisition
Direct 17 Added 0.11%
-
Dec 15
2020
CLGX
Wendy E Lane

Director
BUY
Grant, award, or other acquisition
Direct 4 Added 0.39%
-
Dec 15
2020
CLGX
Claudia F. Munce

Director
BUY
Grant, award, or other acquisition
Direct 34 Added 0.26%
-
Dec 15
2020
CLGX
Pamela H. Patenaude

Director
BUY
Grant, award, or other acquisition
Direct 12 Added 0.4%
-
Dec 15
2020
CLGX
Vikrant Raina

Director
BUY
Grant, award, or other acquisition
Direct 17 Added 0.11%
-
Dec 15
2020
CLGX
Michael Shepherd

Director
BUY
Grant, award, or other acquisition
Direct 17 Added 0.22%
-
Dec 15
2020
CLGX
Jaynie M Studenmund

Director
BUY
Grant, award, or other acquisition
Direct 60 Added 0.17%
-
Dec 15
2020
CLGX
Henry Ward Iv Winship

Director
BUY
Grant, award, or other acquisition
Direct 4 Added 0.39%
-
Dec 15
2020
MDLA
Jimmy C. Duan

Chief Customer Officer and EVP
SELL
Open market or private sale
Direct 14,436 Reduced 6.0%
$493,422 $34.18 p/Share
Dec 15
2020
MDLA
Stanley J Meresman

Director
SELL
Open market or private sale
Indirect 7,500 Reduced 7.89%
$257,850 $34.38 p/Share
Dec 15
2020
CATM
Edward H West

Chief Executive Officer
BUY
Exercise of conversion of derivative security
Direct 49,245 Added 16.41%
-
Dec 15
2020
WPX
Bryan K Guderian

EVP Business Development
SELL
Open market or private sale
Direct 124,192 Reduced 26.15%
$989,810 $7.97 p/Share
Dec 15
2020
CLDR
Robert G Bearden

Chief Executive Officer
SELL
Payment of exercise price or tax liability
Direct 60,751 Reduced 7.25%
$761,818 $12.54 p/Share
Dec 15
2020
CLDR
Robert G Bearden

Chief Executive Officer
BUY
Exercise of conversion of derivative security
Direct 134,702 Added 13.86%
-
Dec 15
2020
CLDR
Jim Frankola

Chief Financial Officer
SELL
Payment of exercise price or tax liability
Direct 77,391 Reduced 5.04%
$970,483 $12.54 p/Share
Dec 15
2020
CLDR
Jim Frankola

Chief Financial Officer
BUY
Exercise of conversion of derivative security
Direct 156,091 Added 9.23%
-
Dec 15
2020
CLDR
Arun Murthy

Chief Product Officer
SELL
Payment of exercise price or tax liability
Direct 88,035 Reduced 9.04%
$1,103,959 $12.54 p/Share
Dec 15
2020
CLDR
Arun Murthy

Chief Product Officer
BUY
Exercise of conversion of derivative security
Direct 177,558 Added 15.43%
-
Dec 15
2020
CLDR
Arun Murthy

Chief Product Officer
SELL
Open market or private sale
Direct 89,523 Reduced 10.11%
$1,108,295 $12.38 p/Share
Dec 15
2020
CLDR
Scott Reasoner

Chief Accounting Officer
SELL
Payment of exercise price or tax liability
Direct 37,742 Reduced 24.92%
$473,285 $12.54 p/Share
Dec 15
2020
CLDR
Scott Reasoner

Chief Accounting Officer
BUY
Exercise of conversion of derivative security
Direct 76,118 Added 33.45%
-
Dec 15
2020
CLDR
Scott Reasoner

Chief Accounting Officer
SELL
Open market or private sale
Direct 38,376 Reduced 33.74%
$474,711 $12.37 p/Share
Dec 15
2020
CLDR
Nick Graziano

Director
BUY
Exercise of conversion of derivative security
Direct 5,358 Added 16.67%
-
Dec 15
2020
CLDR
Jesse Lynn

Director
BUY
Exercise of conversion of derivative security
Direct 5,358 Added 16.67%
-
Dec 15
2020
CLDR
Michael A. Stankey

Director
BUY
Other acquisition or disposition
Indirect 6,568 Added 10.23%
-
Dec 15
2020
CPLG
Keith A. Cline

President & CEO
SELL
Payment of exercise price or tax liability
Direct 71,737 Reduced 7.39%
$477,768 $6.66 p/Share
Dec 15
2020
CPLG
Daniel E Swanstrom Ii

EVP and CFO
SELL
Payment of exercise price or tax liability
Direct 19,017 Reduced 9.24%
$126,653 $6.66 p/Share
Dec 15
2020
CPLG
Mark M. Chloupek

Officer
SELL
Payment of exercise price or tax liability
Direct 23,487 Reduced 7.49%
$156,423 $6.66 p/Share
Dec 15
2020
CPLG
Howard Steven Garfield

SVP, CAO & Treasurer
SELL
Payment of exercise price or tax liability
Direct 5,698 Reduced 9.08%
$37,949 $6.66 p/Share
Dec 15
2020
ODTC
Joseph P O'Connell

Chief Medical Officer
BUY
Grant, award, or other acquisition
Direct 121 Added 3.88%
$1,562 $12.91 p/Share
Dec 15
2020
ODTC
Michael S Hearne

Chief Financial Officer
BUY
Grant, award, or other acquisition
Direct 43 Added 2.0%
$555 $12.91 p/Share
Dec 15
2020
LAB
Ana K. Stankovic

Director
BUY
Grant, award, or other acquisition
Direct 8,221 Added 50.0%
-
Dec 15
2020
ELV
Peter D Haytaian

EVP & Pres Carelon & CarelonRx
SELL
Open market or private sale
Direct 5,833 Reduced 15.16%
$1,824,154 $312.73 p/Share
Dec 15
2020
ELV
Peter D Haytaian

EVP & Pres Carelon & CarelonRx
BUY
Exercise of conversion of derivative security
Direct 5,833 Added 13.16%
$857,043 $146.93 p/Share
Dec 15
2020
EGIO
Robert A Lento

CEO
SELL
Open market or private sale
Direct 24,876 Reduced 1.27%
$100,499 $4.04 p/Share
Dec 15
2020